F-18 Fluorodeoxyglucose Positron Emission Tomography in Pulmonary Cryptococcoma
- 1 September 2003
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Nuclear Medicine
- Vol. 28 (9), 791-793
- https://doi.org/10.1097/01.rlu.0000082680.98898.2b
Abstract
Cryptococcosis is not uncommon. Potential interpretation pitfalls should be kept in mind when fluorodeoxyglucose (FDG) positron emission tomography (PET) is used for differentiating pulmonary nodules and for discriminating infection from malignancy, especially in areas where the prevalence of granulomatous infection is high and in immunocompromised patients. In this case, a nodular mass was shown on chest radiography and computed tomographic (CT) scanning. A consolidated infection or a bronchioloalveolar carcinoma was suspected because the CT scan showed air bronchograms within the mass and another perihilar infiltration. The FDG PET scan clearly delineated the lesion and had intermediately high glucose uptake (standard uptake value, 3.8-4.0), which led to the exclusion of the possibility of bronchioloalveolar carcinoma because most of these tumors had normal or mildly increased FDG accumulation. Cryptococcoma was finally diagnosed. Hence, the CT scan and FDG PET played complementary roles in the differential diagnosis of this nodular mass.Keywords
This publication has 11 references indexed in Scilit:
- F-18 FDG–Positron Emission Tomographic Scanning and Wegener’s GranulomatosisClinical Nuclear Medicine, 2002
- Pulmonary MeningiomaClinical Nuclear Medicine, 2002
- F-18 FDG Uptake in Pulmonary LymphangioleiomyomatosisClinical Nuclear Medicine, 2001
- Pulmonary Fungal InfectionChest, 2001
- Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany.European Journal of Nuclear Medicine and Molecular Imaging, 2000
- Prospective investigation of positron emission tomography in lung nodules.Journal of Clinical Oncology, 1998
- Differentiating Benign from Malignant Lung Lesions Using “Quantitative” Parameters of FDG PET ImagesClinical Nuclear Medicine, 1996
- Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretationSeminars in Nuclear Medicine, 1996
- FDG-PET in infectious lesions: The detection and assessment of lesion activityAnnals of Nuclear Medicine, 1996
- Evaluation of Pulmonary Lesions With FDG-PETChest, 1996